Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Correction to: The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR

Phommasone K. et al, (2020), Malaria Journal, 19

The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR

Phommasone K. et al, (2020), Malaria Journal, 19

Towards harmonization of microscopy methods for malaria clinical research studies

Dhorda M. et al, (2020), Malaria Journal, 19

Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials

Phommasone K. et al, (2020), PLOS ONE, 15, e0228190 - e0228190

Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments—a WWARN individual patient data meta-analysis

(2019), BMC Medicine, 17

Genomic structure and diversity of Plasmodium falciparum in Southeast Asia reveal recent parasite migration patterns

Shetty AC. et al, (2019), Nature Communications, 10

Polymorphisms in Pvkelch12 and gene amplification of Pvplasmepsin4 in Plasmodium vivax from Thailand, Lao PDR and Cambodia

Duanguppama J. et al, (2019), Malaria Journal, 18

Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study

van der Pluijm RW. et al, (2019), The Lancet Infectious Diseases, 19, 952 - 961

Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study

Hamilton WL. et al, (2019), The Lancet Infectious Diseases, 19, 943 - 951

FIELD EVALUATION OF AUTOMATED DIGITAL MALARIA MICROSCOPY: EASYSCAN GO

Vongpromek R. et al, (2019), TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 113, S14 - S15

Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial

Taylor WRJ. et al, (2019), The Lancet, 394, 929 - 938

Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives.

O'Flaherty K. et al, (2019), The Journal of infectious diseases, 220, 1178 - 1187

Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria

Intharabut B. et al, (2019), The Journal of Infectious Diseases, 219, 1483 - 1489

Mapping imported malaria in Bangladesh using parasite genetic and human mobility data

Chang H-H. et al, (2019), eLife, 8

The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial

von Seidlein L. et al, (2019), PLOS Medicine, 16, e1002745 - e1002745

In Vivo Assessments to Detect Antimalarial Resistance

Dhorda MJ. and Dondorp AM., (2019), 105 - 121

Malaria control in India: A national perspective in a regional and global fight to eliminate malaria

Guerin PJ. et al, (2019), Journal of Vector Borne Diseases, 56, 41 - 41

Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors That Affect Treatment Outcomes for P. falciparum Malaria After Artemether-Lumefantrine and Artesunate-Amodiaquine (vol 91, pg 833, 2014)

Venkatesan M. et al, (2019), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 100, 766 - 766

A novel field-based molecular assay to detect validated artemisinin-resistant k13 mutants

Vachot-Ganée L. et al, (2018), Malaria Journal, 17

Effectiveness and safety of 3 and 5 day courses of artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in an area of emerging artemisinin resistance in Myanmar

Tun KM. et al, (2018), Malaria Journal, 17

Load More

Include forthcoming?